Skip to main content
Watch Insiders
Market intelligence
DNTHHealthcare

Dianthus Therapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 17, 2026Adam M VenessSVP, General Counsel and Sec.Sale30,000$80.80$2,423,958
Jun 1, 2026Simrat RandhawaEVP, Head of R&DSale26,530$90.62$2,404,077
May 8, 2026Paula SoteropoulosDirectorSale599$85.47$51,197